The S&P/ASX 200 (Index: ^AXJO) (ASX: XJO) is expected to trade higher today following positive leads from international markets.
Here's a recap:
- FTSE 100 (UK): up 1.03%
- DAX (Germany): up 0.18%
- CAC 40 (France): up 0.04%
- Dow Jones (USA): up 0.64%
- NASDAQ (USA): up 0.53%
In London, mining shares pushed the market higher as new polls showed the Brexit gaining ground. FTSE-listed shares of BHP Billiton Limited (ASX: BHP) and Rio Tinto Limited (ASX: RIO) rose 6.2% and 6.4%, respectively.
US markets also finished higher following comments by Fed Chair Janet Yellen, who again hinted at possible interest rates hikes this year. The energy and materials sectors were best-performing.
Closer to home, the Sydney Futures Exchange is tipping a 15-point, or 0.3%, rise from the S&P/ASX 200.
Shares in focus will include Mayne Pharma Group Ltd (ASX: MYX). This morning, Mayne Pharma announced the US FDA had granted approval of its ANDA for dofetilide capsules in the US. As a result, Mayne Pharma said it has been granted 180-day market exclusivity and will immediately commence commercial launch.
After a significant rally in gold shares yesterday, shares of miners Northern Star Resources Ltd (ASX: NST), EVOLUTION FPO (ASX: EVN) and Newcrest Mining Limited (ASX: NCM) will again be in focus.
Finally, in broker news:
- Morgans analysts cut their Cardno Limited (ASX: CDD) price target 9% to $5.34;
- Deutsche Bank analysts raised their ALS Ltd (ASX: ORE) share price target 81% to $5.30; and,
- Morgan Stanley analysts raised their Healthscope Ltd (ASX: HSO) price target 14% to $2.87, according to Dow Jones Newswires.
